Abstract Search

Background: Male adolescents with hypogonadotropic hypogonadism (HH) or delayed puberty start pubertal induction from 1214 years. Testosterone obtains secondarysexual characteristics and improves psychosocial well being. Gonadotropin releasing hormone (GnRH) or recombinant FSH (rFSH) and human chorionic gonadotropin (hCG) generate testicular growth (fertility) and testicular testosterone production. HCG-rFSH treatment increase testis size and improves the quality of life...

0 shares

ea0078oc4.8 | Oral Communications 4 | BSPED2021

Destination outcome of 1151 gender variant young people presenting to paediatric endocrinology clinics in England and Wales since 2008.

Butler Gary , Adu-Gyamfi Kirpal , Clarkson Kerry , Kleczewski Sara , Roberts Alice , Ward Stephanie , Alvi Sabah , Amin Nadia , Carruthers Paul , Dover Stacey , Eastman Joanna , Mushtaq Talat

Introduction: The destination of young people referred from the NHS Gender Identity Development Service (GIDS) to the two paediatric endocrine centres covering England and Wales has not been analysed previously.Methods: 1151 young people identifying as gender variant were referred from GIDS for an endocrine opinion: 827 patients to University College London Hospital (UCLH) from 2008; 324 to Leeds Childrens Hospital (LCH) from 2013. Outcomes were no...

0 shares

Endocrine Abstracts

Adolescents with HH: what outcome do they want from the gonadotropin stimulation process?

Destination outcome of 1151 gender variant young people presenting to paediatric endocrinology clinics in England and Wales since 2008.

BiosciAbstracts